Saturday, July 11, 2026

Drug profile · INN

abexinostat

abexinostat is a histone deacetylase inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — abexinostat
Class
Route
Patents
0
Programs
1
Data quality
0.70

Quick answer

abexinostat is a histone deacetylase inhibitor.

Key facts

INN abexinostat
Mechanism Histone deacetylase inhibitor
Target Histone deacetylase

Mechanism of action

Histone deacetylase inhibitor

Primary target: Histone deacetylase

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. Abexinostat Phase 2 · Xynomic Pharmaceuticals · Non Hodgkin Lymphoma

Related & competitor drugs

  1. romidepsin Antineoplastic and immunomodulating agents (L01)
  2. belinostat Histone deacetylase inhibitor
  3. givinostat hydrochloride Histone deacetylase inhibitor
  4. panobinostat lactate Histone deacetylase inhibitor
  5. vorinostat Histone deacetylase 3 inhibitor

Frequently asked questions

What is abexinostat?

abexinostat is a histone deacetylase inhibitor.